Ann: Weekly NAV, page-13

First 13 Last

Share
Profile

Follow
TimtamTom

1,459 Posts.

542

04/11/19

12:00

Post #: 41234053
Share

Originally posted by AlexWaller: ↑

Hi Suzee
Whilst MHH should track its weekly NAV, funds like this either trade at a premium or a discount to their NAV based on market sentiment at the time.
Being that MHH is trading well above its NAV, the market currently believes that this fund is worth buying now because it has potential to still get pushed up higher.
At some stage in the future MHH will trade at a discount to its NAV due to poor market sentiment (maybe another Trump tweet). When it trades at a discount, it's a great time to pick up some more.
Also, holders will receive their bonus 7.5% or 2.5% around the middle of Jan 2020. However I don't think this stock will be dumped too much. Those who buy this stock are generally long term holders who are happy to see their 16% yearly gain and take some dividends.
I personally really like Magellan, I trust what they do. Was very impressed by their Flagship Fund (MFF) so can't wait to see how this one goes.
You have a good stock here, trust management and only check it monthly. No need to watch the daily fluctuations.
Alex.

Expand

Great gains today off the back of an all time high US market. Whilst I'm enjoying the ride, I don't see an entry point. I'd prefer to wait for a pull back as these gains are not sustainable IMO.
Alex.
p.s: intra-day NAV $1.54

Last edited by TimtamTom: 04/11/19

MHH Price at posting: $1.68 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 10 more messages in this thread...

First 13 Last

Add MHH (ASX) to my watchlist

Ann: Weekly NAV, page-13

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News